Exogenous Ketones Lower Blood Glucose Level in Rested and Exercised Rodent Models
暂无分享,去创建一个
D. Diamond | M. Kindy | C. Ari | Z. Kovács | D. D'Agostino | Craig R. Goldhagen | Cem Murdun | A. Koutnik | Christopher Q. Rogers | Collin Park | Sahil Bharwani
[1] D. Ault,et al. Effects of an Exogenous Ketone Supplement on Five‐Kilometer Running Performance , 2020, Journal of human kinetics.
[2] K. Clarke,et al. Why a d-β-hydroxybutyrate monoester? , 2020, Biochemical Society transactions.
[3] B. Egan,et al. No Benefit of Ingestion of a Ketone Monoester Supplement on 10-km Running Performance. , 2019, Medicine and science in sports and exercise.
[4] P. Laursen,et al. The Effect of 1,3-Butanediol on Cycling Time-Trial Performance. , 2019, International journal of sport nutrition and exercise metabolism.
[5] P. Hespel,et al. Ketone ester supplementation blunts overreaching symptoms during endurance training overload , 2019, The Journal of physiology.
[6] T. Oron,et al. International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors , 2019, Diabetes Care.
[7] D. Diamond,et al. Delaying latency to hyperbaric oxygen‐induced CNS oxygen toxicity seizures by combinations of exogenous ketone supplements , 2019, Physiological reports.
[8] B. Egan,et al. Intermittent Running and Cognitive Performance after Ketone Ester Ingestion , 2018, Medicine and science in sports and exercise.
[9] D. Diamond,et al. Nutritional ketosis delays the onset of isoflurane induced anesthesia , 2018, BMC Anesthesiology.
[10] Anoop Kumar,et al. Risks Associated with SGLT2 Inhibitors: An Overview. , 2018, Current drug safety.
[11] C. Ebbeling,et al. Management of Type 1 Diabetes With a Very Low–Carbohydrate Diet , 2018, Pediatrics.
[12] John P. A. Ioannidis,et al. Effect of Low-Fat vs Low-Carbohydrate Diet on 12-Month Weight Loss in Overweight Adults and the Association With Genotype Pattern or Insulin Secretion: The DIETFITS Randomized Clinical Trial , 2018, JAMA.
[13] H. Chander,et al. Exogenous ketone salts do not improve cognitive responses after a high-intensity exercise protocol in healthy college-aged males. , 2018, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.
[14] Paul T. Williams,et al. Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study , 2018, Diabetes Therapy.
[15] B. Egan,et al. Effect of acute ingestion of β-hydroxybutyrate salts on the response to graded exercise in trained cyclists , 2018, European journal of sport science.
[16] H. Jelinek,et al. Hyperglycaemia, oxidative stress and inflammatory markers , 2017, Redox report : communications in free radical research.
[17] Olivia K. Faull,et al. On the Metabolism of Exogenous Ketones in Humans , 2017, Front. Physiol..
[18] J. Hawley,et al. Ketone Diester Ingestion Impairs Time-Trial Performance in Professional Cyclists , 2017, Front. Physiol..
[19] J. Little,et al. Nutritional ketone salts increase fat oxidation but impair high-intensity exercise performance in healthy adult males. , 2017, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.
[20] Á. Dobolyi,et al. Adenosine A1 Receptor Antagonism Abolished the Anti-seizure Effects of Exogenous Ketone Supplementation in Wistar Albino Glaxo Rijswijk Rats , 2017, Front. Mol. Neurosci..
[21] P. Laursen,et al. Oral β-hydroxybutyrate salt fails to improve 4-minute cycling performance following submaximal exercise , 2017 .
[22] J. McCarter,et al. A Novel Intervention Including Individualized Nutritional Recommendations Reduces Hemoglobin A1c Level, Medication Use, and Weight in Type 2 Diabetes , 2017, JMIR diabetes.
[23] David N. Thibodeaux,et al. Brain microvasculature defects and Glut1 deficiency syndrome averted by early repletion of the glucose transporter-1 protein , 2017, Nature Communications.
[24] G. Juhász,et al. Exogenous Ketone Supplements Reduce Anxiety-Related Behavior in Sprague-Dawley and Wistar Albino Glaxo/Rijswijk Rats , 2016, Front. Mol. Neurosci..
[25] C. Rae,et al. β-Hydroxybutyrate in the Brain: One Molecule, Multiple Mechanisms , 2016, Neurochemical Research.
[26] Daniel L. Smith,et al. Targeting glucose metabolism for healthy aging , 2016, Nutrition and healthy aging.
[27] S. Neubauer,et al. Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes. , 2016, Cell metabolism.
[28] C. Ari,et al. Effects of exogenous ketone supplementation on blood ketone, glucose, triglyceride, and lipoprotein levels in Sprague–Dawley rats , 2016, Nutrition & Metabolism.
[29] J. Preiser,et al. Time in blood glucose range 70 to 140 mg/dl >80% is strongly associated with increased survival in non-diabetic critically ill adults , 2015, Critical Care.
[30] L. Wood,et al. Acute effects of feeding fructose, glucose and sucrose on blood lipid levels and systemic inflammation , 2014, Lipids in Health and Disease.
[31] A. Constanti,et al. Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release , 2014, Brain, Behavior, and Immunity.
[32] K. Yamagata,et al. Role of Inflammatory Mediators in the Pathogenesis of Epilepsy , 2014, Mediators of inflammation.
[33] C. Ari,et al. Metabolic Therapy with Deanna Protocol Supplementation Delays Disease Progression and Extends Survival in Amyotrophic Lateral Sclerosis (ALS) Mouse Model , 2014, PloS one.
[34] Liang-Jun Yan. Pathogenesis of Chronic Hyperglycemia: From Reductive Stress to Oxidative Stress , 2014, Journal of diabetes research.
[35] M. S. Kirkman,et al. Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association , 2014, Diabetes Care.
[36] T. Seyfried,et al. Ketone supplementation decreases tumor cell viability and prolongs survival of mice with metastatic cancer , 2014, International journal of cancer.
[37] G. Juhász,et al. Lipopolysaccharide induced increase in seizure activity in two animal models of absence epilepsy WAG/Rij and GAERS rats and Long Evans rats , 2014, Brain Research Bulletin.
[38] P. Veggiotti,et al. Dietary Treatments and New Therapeutic Perspective in GLUT1 Deficiency Syndrome , 2014, Current Treatment Options in Neurology.
[39] K. Kimura,et al. Elevated glucose level adversely affects infarct volume growth and neurological deterioration in non‐diabetic stroke patients, but not diabetic stroke patients , 2014, European journal of neurology.
[40] M. Dobreanu,et al. Diabetes and beta cell function: from mechanisms to evaluation and clinical implications , 2013, Biochemia medica.
[41] A. Paoli,et al. Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets , 2013, European Journal of Clinical Nutrition.
[42] Jianping Ye. Mechanisms of insulin resistance in obesity , 2013, Frontiers of Medicine.
[43] Addison K. May,et al. Stress-Induced Hyperglycemia as a Risk Factor for Surgical-Site Infection in Nondiabetic Orthopedic Trauma Patients Admitted to the Intensive Care Unit , 2013, Journal of orthopaedic trauma.
[44] T. Vanitallie,et al. Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. , 2012, Regulatory toxicology and pharmacology : RTP.
[45] K. Clarke,et al. Oral 28-day and developmental toxicity studies of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate. , 2012, Regulatory toxicology and pharmacology : RTP.
[46] U. Baxa,et al. Mitochondrial biogenesis and increased uncoupling protein 1 in brown adipose tissue of mice fed a ketone ester diet , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[47] C. McClain,et al. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. , 2011, JPEN. Journal of parenteral and enteral nutrition.
[48] M. Hochuli,et al. Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial. , 2011, The American journal of clinical nutrition.
[49] G. Juhász,et al. Intracerebroventricularly administered lipopolysaccharide enhances spike–wave discharges in freely moving WAG/Rij rats , 2011, Brain Research Bulletin.
[50] Ferdinando Giacco,et al. Oxidative stress and diabetic complications. , 2010, Circulation research.
[51] P. Mitchell,et al. Carbohydrate nutrition and inflammatory disease mortality in older adults. , 2010, The American journal of clinical nutrition.
[52] R. Bracken,et al. Exercise‐induced hyperglycaemia in the absence of diabetes , 2009, Diabetic medicine : a journal of the British Diabetic Association.
[53] S Del Prato,et al. Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies , 2009, Diabetic medicine : a journal of the British Diabetic Association.
[54] S. Kawahito,et al. Problems associated with glucose toxicity: role of hyperglycemia-induced oxidative stress. , 2009, World journal of gastroenterology.
[55] R. Choue,et al. Comparison of time course changes in blood glucose, insulin and lipids between high carbohydrate and high fat meals in healthy young women , 2009, Nutrition research and practice.
[56] J. Téllez-Zenteno,et al. Occipital seizures induced by hyperglycemia: A case report and review of literature , 2009, Seizure.
[57] K. Inaba,et al. Persistent Hyperglycemia in Severe Traumatic Brain Injury: An Independent Predictor of Outcome , 2009, The American surgeon.
[58] G. Holmes,et al. Brain inflammation initiates seizures , 2008, Nature Medicine.
[59] S. Shapses,et al. Bone mineral density and content during weight cycling in female rats: effects of dietary amylase-resistant starch , 2008, Nutrition & metabolism.
[60] J. Klepper. Glucose transporter deficiency syndrome (GLUT1DS) and the ketogenic diet , 2008, Epilepsia.
[61] J. Wheless. History of the ketogenic diet , 2008, Epilepsia.
[62] J. Cross,et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial , 2008, The Lancet Neurology.
[63] M. Prins,et al. Cerebral Metabolic Adaptation and Ketone Metabolism after Brain Injury , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[64] S. Cheema,et al. Bio F1B hamster: a unique animal model with reduced lipoprotein lipase activity to investigate nutrient mediated regulation of lipoprotein metabolism , 2007, Nutrition & metabolism.
[65] I. Nissim,et al. The ketogenic diet and brain metabolism of amino acids: relationship to the anticonvulsant effect. , 2007, Annual review of nutrition.
[66] G. Juhász,et al. Facilitation of spike-wave discharge activity by lipopolysaccharides in Wistar Albino Glaxo/Rijswijk rats , 2006, Neuroscience.
[67] D. MacGrogan,et al. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis , 2006, BMC Neuroscience.
[68] J. Noebels,et al. A mouse model for Glut-1 haploinsufficiency. , 2006, Human molecular genetics.
[69] E. Thiele,et al. Low-glycemic-index treatment: A liberalized ketogenic diet for treatment of intractable epilepsy , 2005, Neurology.
[70] L. Niskanen,et al. Dietary carbohydrate modification enhances insulin secretion in persons with the metabolic syndrome. , 2005, The American journal of clinical nutrition.
[71] S. Blair,et al. Physical activity and diabetes prevention. , 2005, Journal of applied physiology.
[72] H. Roseman. Progression from obesity to type 2 diabetes: lipotoxicity, glucotoxicity, and implications for management. , 2005, Journal of managed care pharmacy : JMCP.
[73] J. Griffith,et al. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. , 2005, JAMA.
[74] Hong Yang,et al. Glut‐1 deficiency syndrome: Clinical, genetic, and therapeutic aspects , 2005, Annals of neurology.
[75] W. Yancy,et al. A Low-Carbohydrate, Ketogenic Diet versus a Low-Fat Diet To Treat Obesity and Hyperlipidemia , 2004, Annals of Internal Medicine.
[76] R. Veech. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.
[77] C. Stafstrom,et al. Hyperglycemia Lowers Seizure Threshold , 2003, Epilepsy currents.
[78] A. Tagliabue,et al. The ketogenic diet in children, adolescents and young adults with refractory epilepsy: an Italian multicentric experience , 2002, Epilepsy Research.
[79] M. Vranic,et al. Intense exercise has unique effects on both insulin release and its roles in glucoregulation: implications for diabetes. , 2002, Diabetes.
[80] P. Pyzik,et al. The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively. , 2001, Pediatrics.
[81] D. Gilbert,et al. The Ketogenic Diet: Seizure Control Correlates Better With Serum β-Hydroxybutyrate Than With Urine Ketones , 2000, Journal of child neurology.
[82] H. Gerstein,et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview , 2000, The Lancet.
[83] N. Price,et al. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. , 1999, The Biochemical journal.
[84] R. Klein,et al. The association of glycemia and cause-specific mortality in a diabetic population. , 1994, Archives of internal medicine.
[85] J. Halter,et al. Hyperinsulinemia prevents prolonged hyperglycemia after intense exercise in insulin-dependent diabetic subjects. , 1994, The Journal of clinical endocrinology and metabolism.
[86] J. Tobin,et al. The effect of age on insulin response and glucose utilization during four hyperglycemic plateaus , 1993, Experimental Gerontology.
[87] J. Halter,et al. Glucose turnover and its regulation during intense exercise and recovery in normal male subjects. , 1992, Clinical and investigative medicine. Medecine clinique et experimentale.
[88] J. Halter,et al. Glucoregulatory and hormonal responses to repeated bouts of intense exercise in normal male subjects. , 1991, Journal of applied physiology.
[89] I. Hirsch,et al. Insulin and glucagon in prevention of hypoglycemia during exercise in humans. , 1991, The American journal of physiology.
[90] D. Wasserman,et al. Glucagon is a primary controller of hepatic glycogenolysis and gluconeogenesis during muscular work. , 1989, The American journal of physiology.
[91] Lawrence A Leiter,et al. Hyperglycemia After Intense Exercise in IDDM Subjects During Continuous Subcutaneous Insulin Infusion , 1988, Diabetes Care.
[92] N. Kalant,et al. Effect of Age on Glucose Utilization and Responsiveness to Insulin in Forearm Muscle † , 1980, Journal of the American Geriatrics Society.
[93] J. Biebuyck,et al. Ketone bodies are selectively used by individual brain regions. , 1979, Science.
[94] A. Binkiewicz,et al. An effect of ketones on the concentrations of glucose and of free fatty acids in man independent of the release of insulin. , 1974, The Journal of pediatrics.
[95] J. Mayer,et al. Nutrition and athletic performance. , 1959, Journal of the American Medical Association.
[96] M. Huijberts,et al. An integrated medical treatment for type-2 diabetes. , 2014, Diabetes & metabolic syndrome.
[97] H. Brunengraber,et al. with delays in , 2013 .
[98] M. Cooper,et al. Mechanisms of diabetic complications. , 2013, Physiological reviews.
[99] Eric L. Johnson. Glycemic variability in type 2 diabetes mellitus: oxidative stress and macrovascular complications. , 2012, Advances in experimental medicine and biology.
[100] E. Kossoff,et al. Ketosis and the ketogenic diet, 2010: advances in treating epilepsy and other disorders. , 2010, Advances in pediatrics.
[101] R. Robertson,et al. Glucolipotoxicity : Fuel Excess and-Cell Dysfunction , 2008 .
[102] R. Gougeon,et al. The Impact of Low-carbohydrate Diets on Glycemic Control and Weight Management in Patients With Type 2 Diabetes , 2006 .
[103] Nutrition & Metabolism BioMed Central Review Targeting energy metabolism in brain cancer: review and , 2005 .
[104] A. Girija,et al. Seizures in hyperglycemic patients. , 2001, The Journal of the Association of Physicians of India.
[105] G. Reaven,et al. Plasma glucose, insulin and lipid responses to high-carbohydrate low-fat diets in normal humans. , 1983, Metabolism: clinical and experimental.